E-Slides

Access selected presentation slides from EHRA EUROPACE 2011

We would like to thank all those speakers whose generosity has made it possible for us to share these presentations.

Date	Presentation	Speaker
26 Jun 2011	Sudden cardiac death in Europe: how large is the problem?	John Camm
26 Jun 2011	Impact of the ICD on sudden cardiac death across Europe.	Josep Brugada Terradellas
26 Jun 2011	How to better prevent sudden cardiac death in the future: ICD and beyond.	Karl-Heinz Kuck
26 Jun 2011	Leadless pacing.	Panagiotis Vardas
26 Jun 2011	Leadless defibrillation.	Martin Jan Schalij
26 Jun 2011	Leadless rhythm monitoring.	Helmut Puererfellner
26 Jun 2011	Cardiac devices beyond pacemaker and ICD.	Martin Borggrefe
26 Jun 2011	Long QT: ICDs in asymptomatic form or borderline QT patients?	Eric Schulze-Bahr
26 Jun 2011	Brugada Syndrome: ICD or not in asymptomatic or patients with “doubtful” syncope?	Vincent Probst
26 Jun 2011	ARVC: when to implant an asymptomatic person?	Robert Lemery
26 Jun 2011	Laminopathy: when to implant asymptomatic patients?	Stefan Kaab
26 Jun 2011	Management of patients with defibrillator shocks.	Frieder Braunschweig
26 Jun 2011	Management of devices at the end of life.	Pekka Raatikainen
26 Jun 2011	Genetic testing in cardiomyopathies.	Silvia Giuliana Priori
26 Jun 2011	Assessment of patients with palpitations.	Antonio Raviele
27 Jun 2011	Atrial fibrillation and mortality: where is the missing link?	Isabelle C Van Gelder
27 Jun 2011	Pathophysiological effects of single site right ventricular pacing.	Kevin Vernooy
27 Jun 2011	How to prevent unecessary right ventricular pacing?	Jens Cosedis Nielsen
27 Jun 2011	Alternative right ventricular pacing sites.	Christian Butter
27 Jun 2011	Where is the role of additional left ventricular pacing?	Cheuk-Man Yu
27 Jun 2011	ICD shocks: impact on morbidity and mortality.	Frieder Braunschweig
27 Jun 2011	ICD shocks: basic clinical work-up.	Derek Exner
27 Jun 2011	ICD shocks: hot to avoid?	Josef Kautzner
27 Jun 2011	Management of anxiety and patient distress.	Christoph Herrmann-Lingen
27 Jun 2011	Introduction.	John Camm
27 Jun 2011	Rate control.	Harry Crijns
27 Jun 2011	Rhythm control: catheter ablation.	Dipen Chandrakant Shah
27 Jun 2011	Upstream therapy.	Irene Savelieva
27 Jun 2011	Surface ECG quiz: the common, the uncommon, the colibri.	Jacob Atie
27 Jun 2011	How to measure and where to ablate? Interventional treatment of patients with AVNRT.	Katja Zeppenfeld
27 Jun 2011	Interventional treatment of patients with accessory pathway.	Hans Kottkamp
27 Jun 2011	Catheter ablation of atrial fibrillation: where do we stand, where do we go?	Sebastien Knecht
27 Jun 2011	Introduction.	David Wilber
27 Jun 2011	Idiopathic VT	Arash Arya
27 Jun 2011	VT in ischaemic heart disease.	Josef Kautzner
27 Jun 2011	VT in dilated cardiomyopahty.	Fermin Garcia
28 Jun 2011	Syncope and channelopathies: how to work-up the patient?	Christian Wolpert
28 Jun 2011	Syncope in heart failure patients: how to judge and treat?	Jean-Claude Deharo
28 Jun 2011	Syncope in athletes: how to separate the sheep from the goats?	Lluis Mont
28 Jun 2011	Rhythm or rate control: how to decide?	Uta C Hoppe
28 Jun 2011	Antiarrhythmic drug treatment: what is reasonable?	Dan Atar
28 Jun 2011	Catheter ablation: what is possible?	Sebastien Knecht
28 Jun 2011	CRT and AVN abation: what is sensible?	Maurizio Gasparini
28 Jun 2011	Narrow QRS and mechanical dyssynchrony.	Frank Ruschitzka
28 Jun 2011	Standard indication for pacing.	Cheuk-Man Yu
28 Jun 2011	Atrial fibrillation (paroxysmal, permanent, persistent): pulmonary vein ablation and/or CRT?	Johannes Brachmann
28 Jun 2011	CRT-P or CRT-D?	Jean-Jacques Blanc
28 Jun 2011	Outflow tract ventricular tachycardia - always benign?	Arash Arya
28 Jun 2011	VT in the context of myocardial ischaemia.	Martin Jan Schalij
28 Jun 2011	Non-sustained VT in dilated cardiomyopathy with moderately impaired LV-function.	Douglas Packer
28 Jun 2011	Polymorphic catecholaminergic ventricular tachycardia: when is the betablocker not enough?	Silvia Giuliana Priori
28 Jun 2011	Arrhythmogenic right ventricular cardiomyopahty.	Frank Marcus
28 Jun 2011	Dilated cardiomyopathy.	Angel Arenal Maiz
28 Jun 2011	Neuromuscular diseases.	Josef Finsterer
28 Jun 2011	Management of atrial fibrillation patients in 2011: what have we achieved, where are the evidence gaps?	Harry Crijns
28 Jun 2011	Improving outcomes by adequate rhythm control therapy - electrophysiologists’ dream or future reality?	Guenter Breithardt
28 Jun 2011	Detecting atrial fibrillation by devices - between overtreatment and opportunity.	Martin Martinek
28 Jun 2011	Different types of atrial fibrillation: why they should receive different treatments.	Stefan Kaab
29 Jun 2011	Strength and weakness of genetic testing in clinical routine.	Silvia Giuliana Priori
29 Jun 2011	Tailored treatment in LQT.	Dominic James Abrams
29 Jun 2011	Tailored treatment in Brugada.	Lars Eckardt